Munes Fares1, Paul J. Critser2, Maria J. Arruda1, Carolyn M. Wilhelm1, Mantosh S. Rattan3, Sean M. Lang2,4, Tarek Alsaied2,4
Congenital Heart Disease, Vol.14, No.6, pp. 1166-1175, 2019, DOI:10.1111/chd.12840
Abstract Pharmacologic stress cardiovascular magnetic resonance (PSCMR) is a wellestablished and reliable diagnostic tool for evaluation of coronary artery disease in
the adult population. Stress imaging overall and PSCMR in particular is less utilized in
the pediatric population with limited reported data. In this review, we highlight the
potential use of PSCMR in specific pediatric cohorts with congenital and acquired
heart disease, and we review the reported experience. A suggested protocol is presented in addition to two case examples of patients with Kawasaki disease where
PSCMR aided decision making. More >